Comerica Bank’s scPharmaceuticals SCPH Stock Holding History

Comerica Bank’s Portfolio SCPH Stock Details SCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-38,662	Closed	-$147K	–	3799
2025 Q2	$147K	Hold	38,662	–	–	﹤0.01%	2447
2025 Q1	$102K	Buy	38,662 +7,000	+22%	+$22.8K	﹤0.01%	2572
2024 Q4	$112K	Buy	31,662 +17,769	+128%	+$68.1K	﹤0.01%	2537
2024 Q3	$63.4K	Buy	+13,893	New	+$67.2K	﹤0.01%	2717

Other funds holding SCPH

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Comerica Bank's SCPH Position: Q3 2025 in Review

Comerica Bank sold out of scPharmaceuticals (SCPH) in Q3 2025, closing a stake of 38,662 shares — an estimated $147K sold.

Comerica Bank first reported a position in SCPH in Q3 2024 and held it in 4 quarters. The position peaked at $147K in Q2 2025. 110 funds tracked by Wall St. Rank hold SCPH as of Q3 2025.

Comerica Bank reported no remaining scPharmaceuticals position as of Q3 2025 after selling out during the quarter.
Comerica Bank sold 38,662 scPharmaceuticals shares in Q3 2025, an estimated $147K.
Comerica Bank first reported a position in scPharmaceuticals in Q3 2024 and held it in 4 quarters.
Comerica Bank's scPharmaceuticals position peaked at $147K in Q2 2025.
110 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2025.

Based on Comerica Bank's 13F filing for Q3 2025, filed 14 Nov 2025.